82 related articles for article (PubMed ID: 27276)
1. Differential actions of typical and atypical neuroleptic agents on two behavioural effects of apomorphine in the mouse [proceedings].
Costall B; Naylor RJ; Nohria V
Br J Pharmacol; 1978 Jun; 63(2):381P-382P. PubMed ID: 27276
[No Abstract] [Full Text] [Related]
2. The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings].
Ridley RM; Crow TJ
Br J Pharmacol; 1978 Mar; 62(3):393P. PubMed ID: 416868
[No Abstract] [Full Text] [Related]
3. Use of the mouse circling model to demonstrate enhanced striatal actions for oxiperomide and tiapride following denervation [proceedings].
Costall B; Naylor RJ; Nohria V
Br J Pharmacol; 1979 May; 66(1):121P. PubMed ID: 36952
[No Abstract] [Full Text] [Related]
4. Classification of neuroleptics--zotepine.
Puech AJ; Martin P
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):1-3. PubMed ID: 2883676
[TBL] [Abstract][Full Text] [Related]
5. Proceedings: The effects of buprenorphine, morphine and pentazocine on turning behaviour and stereotypy induced by apomorphine in the rat.
Cowan A; Dettmar PW; Walter DS
J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():15P. PubMed ID: 2687
[No Abstract] [Full Text] [Related]
6. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
Kenny M; Leonard BE
J Neurosci Res; 1980; 5(4):291-8. PubMed ID: 6107385
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of new antipsychotic agents: use of animal models.
Puech AJ; Rioux P; Poncelet M; Brochet D; Chermat R; Simon P
Neuropharmacology; 1981 Dec; 20(12B):1279-84. PubMed ID: 6119637
[No Abstract] [Full Text] [Related]
8. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
Melzacka M
Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
[TBL] [Abstract][Full Text] [Related]
9. MJ 9022: correlation between neuroleptic potential and stereotypy.
Sathananthan GL; Sanghvi I; Phillips N; Gershon S
Curr Ther Res Clin Exp; 1975 Nov; 18(5):701-5. PubMed ID: 1208
[No Abstract] [Full Text] [Related]
10. Adaptational phenomena in neuroleptic treatment.
Nielsen IM; Christensen AV; Hyttel J
Adv Biochem Psychopharmacol; 1978; 19():267-74. PubMed ID: 29449
[No Abstract] [Full Text] [Related]
11. The role of gamma-aminobutyric acid in acute and chronic neuroleptic action.
Scheel-Krüger J; Christensen AV
Adv Biochem Psychopharmacol; 1980; 24():233-43. PubMed ID: 6105778
[No Abstract] [Full Text] [Related]
12. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
[No Abstract] [Full Text] [Related]
13. Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia.
Christensen AV; Nielsen IM
Adv Biochem Psychopharmacol; 1980; 24():341-9. PubMed ID: 6105784
[No Abstract] [Full Text] [Related]
14. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
Nohria V
Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
[No Abstract] [Full Text] [Related]
15. Methodone interaction with apomorphine- and amphetamine-induced turning.
Stratten WP
Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
[No Abstract] [Full Text] [Related]
16. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
Georgiev VP; Petkova BP
Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
[TBL] [Abstract][Full Text] [Related]
17. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
18. An organic selenium compound attenuates apomorphine-induced stereotypy in mice.
Machado MS; Rosa RM; Dantas AS; Reolon GK; Appelt HR; Braga AL; Henriques JA; Roesler R
Neurosci Lett; 2006 Dec; 410(3):198-202. PubMed ID: 17052842
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
Lai HC; Carino MA; Horita A
Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
[No Abstract] [Full Text] [Related]
20. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
Gale KN; Murray JP; Horita A
Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
